Vaginal dehydroepiandrosterone compared to other methods of treating
vaginal and vulvar atrophy associated with menopause

Wojciech Pięta; Roman Smolarczyk

doi:10.5114/pm.2020.101943

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

4/2020
vol. 19

Send email

Copy url:

abstract:

Case report

Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause

Wojciech Pięta

¹

,

Roman Smolarczyk

¹

Department of Gynecological Endocrinology, Medical University of Warsaw, Poland

Menopause Rev 2020; 19(4): 195-199

DOI: https://doi.org/10.5114/pm.2020.101943

Online publish date: 2021/01/07

View full text Get citation

PlumX metrics:

During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep. The symptoms of vulvovaginal atrophy are especially troublesome for menopausal women. These symptoms not only disturb the sexual sphere, but also functioning at work and in the family. Based on the literature, a review of contemporary methods of management in the case of symptoms of vulvar atrophy in menopausal women has been performed. The current methods of treating vulvovaginal atrophy in menopausal women are described. The pharmacology of the available dehydroepiandrosterone (DHEA) preparations, both oral and vaginal, was briefly analyzed. Own experiences of using DHEA are presented. Vaginal DHEA has been found to be an effective and safe treatment in menopausal women with symptoms of vaginal atrophy.

keywords:

Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause

Wojciech Pięta 1 , Roman Smolarczyk 1

DHEA, menopause, vulvovaginal atrophy

Wojciech Pięta

¹

,

Roman Smolarczyk

¹